SEB Asset Management’s KalVista Pharmaceuticals KALV Stock Holding History

SEB Asset Management’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-351,305	Closed	-$7.07M	–	718
2026 Q1	$7.07M	Buy	+351,305	New	+$5.66M	0.03%	389

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SEB Asset Management's KALV Position: Q2 2026 in Review

SEB Asset Management sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 351,305 shares — an estimated $7.07M sold.

SEB Asset Management first reported a position in KALV in Q1 2026 and held it in 1 quarter. The position peaked at $7.07M in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

SEB Asset Management reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
SEB Asset Management sold 351,305 KalVista Pharmaceuticals shares in Q2 2026, an estimated $7.07M.
SEB Asset Management first reported a position in KalVista Pharmaceuticals in Q1 2026 and held it in 1 quarter.
SEB Asset Management's KalVista Pharmaceuticals position peaked at $7.07M in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on SEB Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.